<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00929136</url>
  </required_header>
  <id_info>
    <org_study_id>Aarhus University Hospital</org_study_id>
    <nct_id>NCT00929136</nct_id>
  </id_info>
  <brief_title>Peripheral Effects of Endotoxin on Insulin Resistance</brief_title>
  <official_title>The Effect of Regional Inflammation on Metabolism and Insulin Sensitivity in the Lower Extremity.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aarhus University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aarhus University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to isolate the direct effects of endotoxin on glucose, lipid and
      protein metabolism. Eight healthy volunteers are enrolled. The hypothesis is that endotoxin
      will induce insulin resistance, lypolysis and proteolysis acutely.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2009</start_date>
  <completion_date type="Actual">May 2010</completion_date>
  <primary_completion_date type="Actual">May 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>glucose concentration</measure>
    <time_frame>360 minutes observation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Regional arteriovenous amino-acid balance</measure>
    <time_frame>measured at t=180 and 360 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intra-cellular insulin signaling</measure>
    <time_frame>measured at t=0, 120, and, 210 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Regional arteriovenous lipid balance</measure>
    <time_frame>measured at t=180 and 360 minutes</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">8</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Endotoxin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>USP endotoxin</intervention_name>
    <description>Continuous intra-arterial infusion</description>
    <arm_group_label>Endotoxin</arm_group_label>
    <other_name>USP Endotoxin, LOT: G3E069</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Normal health

          2. 22 &lt; BMI &lt; 28

          3. Written Informed Concent

        Exclusion Criteria:

          1. Any disease

          2. Any use of medication

          3. Recent immobilization of a lower extremity
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mads Buhl, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical Department M (Endocrinology and Diabetes), Ã…rhus University Hospital, Denmark</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Niels Moller, M.D., professor, Dmsc</last_name>
    <role>Study Director</role>
    <affiliation>Medical Department M (Endocrinology and Diabetes), Aarhus University Hospital, Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Medical Research Laboratories, Dept. M, Aarhus University Hospital</name>
      <address>
        <city>Aarhus</city>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>October 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 22, 2009</study_first_submitted>
  <study_first_submitted_qc>June 25, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 26, 2009</study_first_posted>
  <last_update_submitted>October 1, 2010</last_update_submitted>
  <last_update_submitted_qc>October 1, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 4, 2010</last_update_posted>
  <responsible_party>
    <name_title>Niels Moller M.D. and Mads Buhl, M.D</name_title>
    <organization>University of Aarhus</organization>
  </responsible_party>
  <keyword>Endotoxin</keyword>
  <keyword>Insulin resistance</keyword>
  <keyword>Lipolysis</keyword>
  <keyword>Proteolysis</keyword>
  <keyword>Intracellular Insulin Signaling</keyword>
  <keyword>Regional effects of inflammation/endotoxin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin, Globin Zinc</mesh_term>
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

